Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IMC-3C5 |
Synonyms | |
Therapy Description |
IMC-3C5 (LY3022856) is a monoclonal antibody, which binds FLT4 (VEGFR3) to prevent ligand based activation, which may result in decreased angiogenesis and tumor growth (PMID: 27566701). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMC-3C5 | LY3022856|LY-3022856 | VEGFR3 Antibody 1 | IMC-3C5 (LY3022856) is a monoclonal antibody, which binds FLT4 (VEGFR3) to prevent ligand based activation, which may result in decreased angiogenesis and tumor growth (PMID: 27566701). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|